OGEN INTELLIGENCE PHARMACEUTICAL COMPANY
AI, machine learning and molecular modeling have been used to design new ligand with specific characteristics. We have used a huge database to identify new scaffold based on approved ligands and develop innovative formulation. We have developed long acting drugs for chemotherapy, anti-pain & antibiotic purpose using polymer and FDA approved medicine.
- Our knowledge based company, OGEN Intelligence Pharmaceutical company ,
provides the most advanced innovative technology in controlled release products. - Artificial Intelligence , Molecular Modeling & Machine Learning are used to find new ligands based on approved drugs and optimized scale up of procedure.
- The mixed strategy (computational & experimental procedure) minimized cost and predicted ligands more efficient than previous lead ligands.
- This is new opportunity to treat the patients through chemotherapy by controlled release drug formulation.
Big concepts
Poly (ortho-esters) were developed to formulate long-acting products with specific scaffolds. We synthesized poly ortho-ester polymer and used in new formulation.
AI( Artificial intelligence), machine learning and molecular modeling have been used to predict new ligand with specific characteristics. We have used big databases to find new scaffold based on approved ligands .
AI have used in all technical procedure. QBD ( Quality By Design) is an essential part of the modern pharmaceutical quality. We have optimized products and new formulation by this method and confirmed our new formulation and production.
You may also be intersted in
